Results 121 to 130 of about 136,276,834 (195)

Three cytochrome P450 enzymes consecutively catalyze the biosynthesis of furanoclerodane precursors in Salvia species. [PDF]

Plant Commun
Lin R, Li H, Xiao Y, Wang Z, Liu L, Saalbach G, Martins C, Furry M, Vanderwal CD, Martin C, Tatsis EC.   +10 more
europepmc   +1 more source

Diterpenes with Abietane and Clerodane Skeletons from the Mexican <i>Salvia</i> Species as Potential Bioactive Compounds. [PDF]

Molecules
Ortiz-Mendoza N, Bazany-Rodríguez IJ, Martínez-Gordillo MJ, Basurto-Peña FA, Dorazco-González A, Fragoso-Martínez I, González-Trujano ME, Martínez Ambriz E, Soto-Hernández M, Aguirre-Hernández E.   +9 more
europepmc   +1 more source

Xylazine-induced diuresis in rats is attenuated by κ-opioid receptor and α2-adrenoceptor antagonists. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Inan S, Rawls SM.
europepmc   +1 more source

Protocol for selective DREADD-based chemogenetic inhibition of GABAergic amygdala neurons receiving hippocampal projections in rats. [PDF]

STAR Protoc
Cicciarelli F, Concina G, Milano L, Renna A, Sacchetti B.   +4 more
europepmc   +1 more source

Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ‑OR Agonist

ACS Central Science, 2017
Jeremy J. Roach, Yusuke Sasano, Cullen L. Schmid, Saheem Zaidi, Vsevolod Katritch, Raymond C. Stevens, Laura M. Bohn, Ryan A. Shenvi   +7 more
doaj   +1 more source

κ-opioid receptor: from analgesic target to neuroimmune hub. [PDF]

Front Pharmacol
Tan Q, Zheng M, Xing H.
europepmc   +1 more source

Semi-synthesis in the exploration of opioid-targeting natural products.

Nat Prod Rep
Riley AP.
europepmc   +1 more source

Drug repositioning identifies salvinorin A and deacetylgedunin (DCG) enriched plant extracts as novel inhibitors of Mpro, RBD-ACE2 and TMPRRS2 proteins. [PDF]

RSC Adv
Shayo MJ, Samwel B, Shadrack DM, Cassel J, Salvino JM, Montaner LJ, Deogratias G, Tietjen I, Kiruri L, Hilonga S, Innocent E.   +10 more
europepmc   +1 more source

Narcotics through time: exploring historical origins, synthetic advances, and clinical progress. [PDF]

Future Med Chem
Kalita RC, Sharma S, Samanta S, Patle D.
europepmc   +1 more source

Limitations and potential of κOR biased agonists for pain and itch management. [PDF]

Neuropharmacology
El Daibani A, Madasu MK, Al-Hasani R, Che T.   +3 more
europepmc   +1 more source